An amendment to Spectranetics' existing credit facilities has increased the company's total credit facility to $140 million, which consists of a $90 million term loan and $50 million revolving credit line. The new facility replaces the company's earlier $60 million term loan and $50 million revolver, with the term loan's maturity extended to March 2021.
$140M debt refinancing announced by Spectranetics
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.